The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma

References

• Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res. 2011;183:25–35. Epub 2011/04/22.
   PubMedGoogle Scholar
• Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060. Epub 2011/03/18.
   PubMed Web of Science ®Google Scholar
• Hideshima T, Mitsiades C, Tonon G, et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585–598. Epub 2007/07/25.
   PubMed Web of Science ®Google Scholar
• Alexander DD, Mink PJ, Adami HO, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2007;120(Suppl 12):40–61. Epub 2007/04/04.
   PubMed Web of Science ®Google Scholar
• Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs. 2017;33(3):225–236. Epub 2017/07/10.
   PubMed Web of Science ®Google Scholar
• Smith A, Howell D, Patmore R, et al. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105(11):1684–1692. Epub 2011/11/03.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–10518. Epub 2008/07/30.
   PubMed Web of Science ®Google Scholar
• Wang H, Peng R, Wang J, et al. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin Epigenetics. 2018;10:59, Epub 2018/05/02.
   PubMed Web of Science ®Google Scholar
• Handa H, Murakami Y, Ishihara R, et al. The role and function of microRNA in the pathogenesis of Multiple myeloma. Cancers (Basel). 2019;11(11):1738.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. Epub 2004/01/28.
   PubMed Web of Science ®Google Scholar
• Pourhanifeh MH, Mahjoubin-Tehran M, Shafiee A, et al. MicroRNAs and exosomes: small molecules with big actions in multiple myeloma pathogenesis. IUBMB Life. 2020;72(3):314–333. Epub 2019/12/13.
   PubMed Web of Science ®Google Scholar
• Masri AA, Price-Troska T, Chesi M, et al. MicroRNA expression analysis in multiple myeloma. Blood. 2005;106(11):1554.
   Web of Science ®Google Scholar
• Soliman AM, Lin TS, Mahakkanukrauh P, et al. Role of microRNAs in diagnosis, prognosis and management of multiple myeloma. Int J Mol Sci. 2020;21(20):7539. Epub 2020/10/18.
   PubMed Web of Science ®Google Scholar
• Pula A, Robak P, Robak T. MicroRNA in Multiple myeloma – a Role in pathogenesis and prognostic significance. Curr Med Chem. 2021;28(33):6753–6772. Epub 2021/05/06.
   PubMed Web of Science ®Google Scholar
• Zhu B, Ju S, Chu H, et al. The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma. Oncol Lett. 2018;15(5):6094–6106. Epub 2018/05/08.
   PubMed Web of Science ®Google Scholar
• Tiruneh T, Melku M. Circulating MicroRNAs in multiple myeloma: a literature review. Clin Lab. 2020;66(12). Epub 2020/12/19.
   PubMed Web of Science ®Google Scholar
• Gupta N, Kumar R, Seth T, et al. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma. J Cancer Res Clin Oncol. 2019;145(6):1601–1611. Epub 2019/03/21.
   PubMed Web of Science ®Google Scholar
• Morin RD, O’Connor MD, Griffith M, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008;18(4):610–621. Epub 2008/02/21.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liao JM, Zeng SX, et al. P53 downregulates down syndrome-associated DYRK1A through miR-1246. EMBO Rep. 2011;12(8):811–817. Epub 2011/06/04.
   PubMed Web of Science ®Google Scholar
• Ren Y, Li X, Wang W, et al. Expression of peripheral blood miRNA-720 and miRNA-1246 can be used as a predictor for outcome in multiple myeloma patients. Clin Lymphoma Myeloma Leuk. 2017;17(7):415–423. Epub 2017/06/12.
   PubMed Web of Science ®Google Scholar
• Kumar S, Paiva B, Anderson KC, et al. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–ee46. Epub 2016/08/12.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. Epub 2002/02/16.
   PubMed Web of Science ®Google Scholar
• Condrat CE, Thompson DC, Barbu MG, et al. miRNAs as biomarkers in disease: latest findings regarding their Role in diagnosis and prognosis. Cells. 2020;9(2):276. Epub 2020/01/26.
   PubMed Web of Science ®Google Scholar
• Filipow S, Laczmanski L. Blood circulating miRNAs as cancer biomarkers for diagnosis and surgical treatment response. Front Genet. 2019;10:169, Epub 2019/03/28.
   PubMed Web of Science ®Google Scholar
• Oura K, Fujita K, Morishita A, et al. Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma. Oncol Lett. 2019;18(1):882–890. Epub 2019/07/11.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X, Situ B, et al. Rapid electrochemical biosensor for sensitive profiling of exosomal microRNA based on multifunctional DNA tetrahedron assisted catalytic hairpin assembly. Biosens Bioelectron. 2021;183:113205, Epub 2021/04/05.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Z, Zhu X, et al. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Int J Clin Oncol. 2020;25(1):89–99. Epub 2019/09/12.
   PubMed Web of Science ®Google Scholar
• Chuma M, Toyoda H, Matsuzaki J, et al. Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Hepatology Research: Off J Japan Soc Hepatol. 2019;49(7):810–822. Epub 2019/03/29.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xie YJ, Xu Q, et al. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance. Gynecol Oncol. 2015;138(3):683–688. Epub 2015/06/16.
   PubMed Web of Science ®Google Scholar
• Kawaguchi N, Zhang TT, Nakanishi T. Involvement of CXCR4 in normal and abnormal development. Cells. 2019;8(2):185. Epub 2019/02/23.
   PubMed Web of Science ®Google Scholar
• Liu HT, Fan WX. MiRNA-1246 suppresses the proliferation and migration of renal cell carcinoma through targeting CXCR4. Eur Rev Med Pharmacol Sci. 2020;24(11):5979–5987. Epub 2020/06/24.
   PubMed Web of Science ®Google Scholar
• Xu X, Cao L, Zhang Y, et al. MicroRNA-1246 inhibits cell invasion and epithelial mesenchymal transition process by targeting CXCR4 in lung cancer cells. Cancer Biomarkers: Section A of Disease Markers. 2018;21(2):251–260. Epub 2017/11/25.
   PubMed Web of Science ®Google Scholar
• Roccaro AM, Mishima Y, Sacco A, et al. CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation. Cell Rep. 2015;12(4):622–635. Epub 2015/07/21.
   PubMed Web of Science ®Google Scholar
• Torii C, Maishi N, Kawamoto T, et al. miRNA-1246 in extracellular vesicles secreted from metastatic tumor induces drug resistance in tumor endothelial cells. Sci Rep. 2021;11(1):13502. Epub 2021/07/07.
   PubMed Web of Science ®Google Scholar
• Xie B, Li L, Zhang Z, et al. MicroRNA-1246 by targeting AXIN2 and GSK-3beta overcomes drug resistance and induces apoptosis in chemo-resistant leukemia cells. J Cancer. 2021;12(14):4196–4208. Epub 2021/06/08.
   PubMed Web of Science ®Google Scholar
• Qiu W, Guo X, Li B, et al. Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells. Mol Ther; 2021: 3449–3464. Epub 2021/07/05.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang L, Yu G, et al. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer. Cancer Chemother Pharmacol. 2020;86(6):761–772. Epub 2020/10/18.
   PubMed Web of Science ®Google Scholar